Scarica l'app Stockscreener
17.03
2.57%
-0.45
Dopo l'orario di chiusura:
16.95
-0.08
-0.47%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IMVT Giù?
Forum
Previsione
Precedente Chiudi:
$17.48
Aprire:
$17.62
Volume 24 ore:
2.06M
Relative Volume:
1.37
Capitalizzazione di mercato:
$2.97B
Reddito:
-
Utile/perdita netta:
$-382.71M
Rapporto P/E:
-6.50
EPS:
-2.62
Flusso di cassa netto:
$-325.64M
1 W Prestazione:
+0.77%
1M Prestazione:
+5.12%
6M Prestazione:
+15.15%
1 anno Prestazione:
-43.10%
Intervallo 1D:
$16.59
$17.62
Intervallo di 1 settimana:
$15.95
$17.84
Portata 52W:
$12.72
$32.10
Immunovant Inc Stock (IMVT) Company Profile
Nome
Immunovant Inc
Settore
Industria
Telefono
917-580-3099
Indirizzo
320 WEST 37TH STREET, NEW YORK, NY
Confronta IMVT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMVT
Immunovant Inc
|
17.03 | 3.05B | 0 | -382.71M | -325.64M | -2.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immunovant Inc Stock (IMVT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Neutral |
| 2025-03-03 | Iniziato | Jefferies | Hold |
| 2025-01-03 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-10-09 | Reiterato | Oppenheimer | Outperform |
| 2024-03-28 | Iniziato | Oppenheimer | Outperform |
| 2024-03-13 | Iniziato | Goldman | Buy |
| 2024-02-20 | Iniziato | JP Morgan | Overweight |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-10-13 | Aggiornamento | UBS | Neutral → Buy |
| 2023-09-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-01 | Iniziato | BofA Securities | Buy |
| 2023-04-25 | Iniziato | Citigroup | Buy |
| 2023-03-31 | Iniziato | Piper Sandler | Overweight |
| 2023-03-30 | Iniziato | Stifel | Buy |
| 2023-02-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-01-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-09-26 | Downgrade | UBS | Buy → Neutral |
| 2021-12-08 | Iniziato | Wells Fargo | Equal Weight |
| 2021-08-03 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-08-02 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2021-06-01 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-06-01 | Downgrade | Stifel | Buy → Hold |
| 2020-10-28 | Iniziato | UBS | Buy |
| 2020-10-12 | Iniziato | Guggenheim | Buy |
| 2020-10-08 | Iniziato | Stifel | Buy |
| 2020-10-02 | Iniziato | Credit Suisse | Outperform |
| 2020-08-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-25 | Iniziato | Raymond James | Outperform |
| 2020-07-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-02-24 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Immunovant Inc Borsa (IMVT) Ultime notizie
Will Immunovant Inc. stock outperform value stocksNew Guidance & Real-Time Market Trend Scan - newser.com
How hedge fund analytics apply to Immunovant Inc. stockDollar Strength & Short-Term Trading Alerts - newser.com
Reversal indicators forming on Immunovant Inc. stockWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Immunovant (NASDAQ:IMVT) Insider Michael Geffner Sells 1,272 Shares - MarketBeat
Immunovant (NASDAQ:IMVT) Shares Up 7.2%Here's What Happened - MarketBeat
Immunovant’s chief technology officer sells $25,835 in stock By Investing.com - Investing.com Australia
Statistical indicators supporting Immunovant Inc.’s strengthEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Will breakout in Immunovant Inc. lead to full recovery2025 Technical Patterns & AI Driven Price Predictions - newser.com
Immunovant Inc. stock momentum explainedMarket Weekly Review & Daily Growth Stock Investment Tips - newser.com
Smart tools for monitoring Immunovant Inc.’s price action2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37 - MSN
Published on: 2025-10-09 06:28:21 - newser.com
Using Ichimoku Cloud for Immunovant Inc. technicalsMarket Activity Summary & Real-Time Volume Analysis Alerts - newser.com
Is Immunovant Inc. forming a bottoming baseJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Analyzing drawdowns of Immunovant Inc. with statistical toolsJuly 2025 Short Interest & AI Enhanced Trade Execution Alerts - newser.com
Why Immunovant Inc. stock remains undervalued2025 Bull vs Bear & Stock Market Timing Techniques - newser.com
Platinum Investment Management Ltd. Grows Position in Immunovant, Inc. $IMVT - MarketBeat
Where is Immunovant (IMVT) Heading According to Analysts? - MSN
Immunovant (NASDAQ:IMVT) Given New $33.00 Price Target at JPMorgan Chase & Co. - MarketBeat
12 Best Strong Buy Stocks to Invest in According to Wall Street - Insider Monkey
Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue? - MSN
Is Asahi India Glass Limited One of the Top Picks for Growth Investors in YEARPrice Action Analysis & Free Phenomenal Trading Returns - earlytimes.in
What analysts say about Immunovant Inc stockFinancial Sector Performance & Free Proven Portfolio Growth Strategies - earlytimes.in
Banque Pictet & Cie SA Has $2.02 Million Stock Holdings in Immunovant, Inc. $IMVT - MarketBeat
Insider Sale: President & Immunovant CEO of $ROIV Sells 683,818 Shares - Quiver Quantitative
Immunovant, Inc. (NASDAQ:IMVT) Receives $33.60 Consensus PT from Analysts - MarketBeat
Aug Spikes: Is Immunovant Inc. a play on infrastructure spendingEarnings Recap Summary & Precise Buy Zone Tips - خودرو بانک
FOMO Trade: What are Immunovant Incs earnings expectations2025 Bull vs Bear & Fast Gaining Stock Strategy Reports - khodrobank.com
Gap Down: Should value investors consider Immunovant IncJuly 2025 Highlights & Safe Entry Point Identification - خودرو بانک
Live market analysis of Immunovant Inc.2025 Market Trends & Community Supported Trade Ideas - newser.com
Published on: 2025-09-19 07:03:28 - khodrobank.com
Trading Recap: Why is WANG LEE GROUP Inc stock going down2025 Fundamental Recap & Accurate Technical Buy Alerts - khodrobank.com
Sentiment Watch: What are analysts price targets for Immunovant IncJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - khodrobank.com
Highs Report: How is Hoth Therapeutics Inc. managing supply chain issues2025 Market Trends & Daily Volume Surge Signals - khodrobank.com
IMMUNOVANT INVESTIGATION INITIATED BY FORMER LOUISIANA - GlobeNewswire
Published on: 2025-09-18 21:39:43 - خودرو بانک
Aug Outlook: Does Immunovant Inc. have pricing powerWeekly Stock Summary & Real-Time Market Sentiment Reports - خودرو بانک
CENTURY ALUMINUM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Century Aluminum Co. - GlobeNewswire Inc.
Dow Update: What is Immunovant Inc.’s book value per share2025 Stock Rankings & Fast Entry High Yield Stock Tips - خودرو بانک
Investment Recap: What dividend growth rate does Immunovant Inc offer2025 Market WrapUp & Weekly High Return Forecasts - khodrobank.com
Earnings Update: Will Immunovant Inc. benefit from geopolitical trendsTrade Risk Assessment & Capital Efficiency Focused Strategies - خودرو بانک
Rate Cut: Will Immunovant Inc. benefit from geopolitical trends2025 Technical Patterns & Daily Growth Stock Tips - خودرو بانک
Earnings Update: What drives Immunovant Incs stock priceJuly 2025 Movers & Low Risk High Reward Trade Ideas - خودرو بانک
Buyback Watch: Will Immunovant Inc announce a stock splitMarket Activity Report & AI Enhanced Trade Execution Alerts - khodrobank.com
Surprises Report: Is Immunovant Inc affected by consumer sentiment2025 Key Lessons & High Accuracy Trade Signal Alerts - خودرو بانک
Profit Recap: Can Monro Inc. weather a recessionWeekly Market Report & Stepwise Swing Trade Plans - خودرو بانک
Immunovant, Inc. $IMVT Shares Bought by Woodline Partners LP - MarketBeat
Immunovant Inc Azioni (IMVT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Immunovant Inc Azioni (IMVT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Stout Jay S | Chief Technology Officer |
Oct 08 '25 |
Sale |
16.30 |
1,585 |
25,836 |
203,334 |
| Stout Jay S | Chief Technology Officer |
Jul 23 '25 |
Sale |
18.15 |
2,805 |
50,911 |
204,919 |
| Geffner Michael | Chief Medical Officer |
Jul 23 '25 |
Sale |
18.15 |
2,385 |
43,288 |
221,825 |
| Geffner Michael | Chief Medical Officer |
Jul 09 '25 |
Sale |
17.24 |
1,160 |
19,998 |
224,210 |
| Stout Jay S | Chief Technology Officer |
Jul 09 '25 |
Sale |
17.24 |
1,519 |
26,188 |
207,724 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):